International Experience with Lung Transplantation for COVID-19 Associated Acute Respiratory Distress Syndrome

Machuca, T.N.; Bharat, A.; Kurihara, C.; R. Garza-Castillon, J.; Kim, S.; Manerikar, A.; Pelaez, A.; Pipkin, M.; Shahmohammadi, A.; Rackauskas, M.; Kg, S.; Balakrishnan, K.; Jindal, A.; Schaheen, L.; Hashimi, S.; Bhuddhdev, B.; Arjuna, A.; Rosso, L.; Palleschi, A.; Lang, C.; Jaksch, P.; Nosotti, M.; Hoetzenecker, K.

The Covid-19 pandemic has infected millions of people across the world and caused several thousands of deaths. Given advances in extracorporeal life suppirt technology, ECMO for Covid-19 ARDS has proven to be successful in sustaining life, however has left a significant number of patients fully dependen on devices and incapable of beaing weaned. Lung transplantation, as a well-established therapy for end-stage lung disease, has been considered for some patients with Covid-19 ARD in the absence of lung recovery and the presence of findings suggestive of end-stage lung disease

International Experience with Lung Transplantation for COVID-19 Associated Acute Respiratory Distress Syndrome / T.N. Machuca, A. Bharat, C. Kurihara, R.G. Jr, S. Kim, A. Manerikar, A. Pelaez, M. Pipkin, A. Shahmohammadi, M. Rackauskas, S. Kg, K. Balakrishnan, A. Jindal, L. Schaheen, S. Hashimi, B. Bhuddhdev, A. Arjuna, L. Rosso, A. Palleschi, C. Lang, P. Jaksch, M. Nosotti, K. Hoetzenecker. - In: THE JOURNAL OF HEART AND LUNG TRANSPLANTATION. - ISSN 1053-2498. - 40:4(2021 Apr), pp. S12-S12. ((Intervento presentato al convegno The ISHLT2021 Annual Meeting & Scientific Sessions nel 2021.